1. Home
  2. NEXN vs TENX Comparison

NEXN vs TENX Comparison

Compare NEXN & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexxen International Ltd. American Depository Shares

NEXN

Nexxen International Ltd. American Depository Shares

HOLD

Current Price

$8.59

Market Cap

381.1M

Sector

Technology

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$11.35

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXN
TENX
Founded
2007
1967
Country
Israel
United States
Employees
909
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
381.1M
317.8M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
NEXN
TENX
Price
$8.59
$11.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
3
Target Price
$11.56
$29.67
AVG Volume (30 Days)
227.7K
626.6K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.60
$5.34
52 Week High
$11.59
$18.38

Technical Indicators

Market Signals
Indicator
NEXN
TENX
Relative Strength Index (RSI) 60.40 48.36
Support Level $8.01 $10.87
Resistance Level $8.62 $12.75
Average True Range (ATR) 0.35 0.64
MACD -0.01 0.04
Stochastic Oscillator 77.38 57.50

Price Performance

Historical Comparison
NEXN
TENX

About NEXN Nexxen International Ltd. American Depository Shares

Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and TV that helps empower advertisers, agencies, digital publishers, broadcasters, and others. The Digital Advertising Ecosystem of the company includes demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. The company operates in America, APAC, EMEA, and Rest of America, with majority revenue from America.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: